Abstract
Background: Aciclovir is the drug of choice for severe systemic herpes virus infections. Nephrotoxicity is one of the clinically significant adverse effects of this drug, but studies examining nephrotoxicity in children are scarce.
Objective: To identify risk factors for aciclovir-associated nephrotoxicity in the pediatric population.
Patients and methods: A retrospective review was conducted on all children (mean age 81 months; n = 126 [74 boys]) who were treated with aciclovir in a tertiary center between July 2005 and January 2006 and who met our inclusion criteria. Glomerular filtration rate (GFR) was calculated on the first day of treatment and at the peak measured creatinine level while on therapy, using Schwartz’s method.
Results: Aciclovir therapy was associated with a significant increase in serum creatinine levels and a parallel decrease in GFR (n = 93; both p ≤ 0.0001). Children with immunosuppression who received a variety of other nephrotoxic drugs exhibited more severe nephrotoxicity than those not receiving nephrotoxic drugs. In multiple regression analysis, the use of nephrotoxic drugs (p = 0.02) and impaired GFR at baseline (p = 0.04) were predictive for nephrotoxicity.
Conclusions: Within the recommended age-dependent dosage schedule of aciclovir there was no effect of dose per kg, age, or sex on nephrotoxicity. The predictors of aciclovir nephrotoxicity were the concomitant use of nephrotoxic drugs and impaired GFR at baseline.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.2165%2F00148581-200810020-00008/MediaObjects/40272_2012_10020135_Tab1.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.2165%2F00148581-200810020-00008/MediaObjects/40272_2012_10020135_Tab2.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.2165%2F00148581-200810020-00008/MediaObjects/40272_2012_10020135_Tab3.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.2165%2F00148581-200810020-00008/MediaObjects/40272_2012_10020135_Tab4.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.2165%2F00148581-200810020-00008/MediaObjects/40272_2012_10020135_Tab5.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.2165%2F00148581-200810020-00008/MediaObjects/40272_2012_10020135_Tab6.jpg)
Similar content being viewed by others
References
Wasiewski WW, Fishman MA. Herpes simplex encephalitis: the brain biopsy controversy. J Pediatr 1988; 113: 575–8
Bryson YY. The use of acyclovir in children. Pediatr Infect Dis 1984; 3: 345–8
Balfour Jr HH. Intravenous acyclovir for varicella in immunocompromised children. J Pediatr 1984; 104: 134–6
Krieble BF, Rudy DW, Glick MR, et al. Acyclovir neurotoxicity and nephrotoxicity: the role for hemodialysis [case report]. Am J Med Sci 1993; 305: 36–9
Eck P, Silver SM, Clark EC. Acute renal failure and coma after a high dose of oral acyclovir. N Engl J Med 1991; 325: 1178–9
Keeney RE, Kirk LE, Bridgen D. Acyclovir tolerance in humans. Am J Med 1992; 73: 176–81
Sawyer MH, Webb DE, Balow JE, et al. Acyclovir-induced renal failure: clinical course and histology. Am J Med 1988; 84: 1067–71
Bianchetti MG, Roduit C, Oetliker OH. Acyclovir-induced renal failure: course and risk factors. Pediatr Nephrol 1991; 5: 238–9
Izzedine H, Launay-Vacher V, Deray G. Antiviral drug-induced nephrotoxicity. Am J Kid Dis 2005; 45: 804–17
Prazella MA. Drug induced renal failure: update on new medications and unique mechanisms of nephrotoxicity. Am J Med Sci 2003; 325: 349–62
Ahmad T, Simmonds M, Mclver AG, et al. Reversible renal failure in renal transplant patients receiving oral acyclovir prophylaxis. Pediatr Nephrol 1994; 8: 489–91
Vachvanichsanong P, Patamasucon P, Malagon M, et al. Acute renal failure in a child associated with acyclovir. Pediatr Nephrol 1995; 9: 346–7
Vomiero G, Blair C, Robb I, et al. Combination of ceftriaxone and acyclovir-an underestimated nephrotoxic potential? Pediatr Nephrol 2002; 17: 633–7
Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents. Pediatr Clin North Am 1987; 34: 571–90
Kowalcvzyk AL, Dupuis LL, Domaratzki J. Acyclovir toxicity in pediatric patients: incidence and risk factor [abstract p-43]. Proceedings of the winter meeting of the American College of Clinical Pharmacy; 1991 Dec; Boston. Boston (MA): American College of Clinical Pharmacy, 1991
Koren G, Klein J, MacLeod M. The dissociation between aminoglycoside serum concentrations and nephrotoxicity. Life Sci 1988; 43: 1817–23
Koren G, Lau A, Kenyon CF, et al. Clinical course and pharmacokinetics following a massive overdose of amphotericin B in a neonate. Toxicol Clin Toxicol 1990; 28: 371–8
Acknowledgments
This study was supported by a grant from the Canadian Institutes of Health Research (CIHR). G. Koren is the Ivey Chair in Molecular Toxicology, Department of Medicine, University of Western Ontario, Ontario, Canada.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schreiber, R., Wolpin, J. & Koren, G. Determinants of Aciclovir-Induced Nephrotoxicity in Children. Pediatr-Drugs 10, 135–139 (2008). https://doi.org/10.2165/00148581-200810020-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00148581-200810020-00008